Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 Apr;57(4):338–342. doi: 10.1136/thorax.57.4.338

Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland

U Hodgson 1, T Laitinen 1, P Tukiainen 1
PMCID: PMC1746288  PMID: 11923553

Abstract

Background: The prevalence of sporadic and familial idiopathic pulmonary fibrosis (IPF) cases in Finland was evaluated according to the revised recommendations of the American Thoracic Society.

Methods: All Finnish pulmonary clinics (n=29) were included in the primary screening. Hospital data bases were used to identify patients with the diagnosis "alveolitis fibroticans idiopathica" (J84.1 in ICD-10 classification). The total number of patients with IPF was extrapolated based on the evaluation of random samples of case records in different centres. Families with more than one potentially affected member were identified from a questionnaire study and the diagnosis was verified from the medical records.

Results: Using this approach, the nationwide prevalence of IPF in Finland was estimated to be 16–18/100 000. In 90% of the patients lung involvement was assessed by high resolution computed tomographic (HRCT) scanning and in 31% a surgical biopsy specimen was available, further confirming the diagnosis. Seventeen multiplex families with 2–5 affected family members were identified, giving a prevalence of 5.9/million for familial IPF in Finland. Both multiplex and sporadic families were clustered in Eastern Finland. This clustering reflects the demographic history of Finland in the 16th century and suggests that multiplex families may share a common ancestor in the last 20–25 generations.

Conclusion: The familial form explained 3.3–3.7% of all Finnish cases of IPF diagnosed according to the revised international guidelines. Geographical clustering of multiplex families suggests a recent founder effect in patients with familial IPF.

Full Text

The Full Text of this article is available as a PDF (203.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bitterman P. B., Rennard S. I., Keogh B. A., Wewers M. D., Adelberg S., Crystal R. G. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med. 1986 May 22;314(21):1343–1347. doi: 10.1056/NEJM198605223142103. [DOI] [PubMed] [Google Scholar]
  2. Coultas D. B., Zumwalt R. E., Black W. C., Sobonya R. E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994 Oct;150(4):967–972. doi: 10.1164/ajrccm.150.4.7921471. [DOI] [PubMed] [Google Scholar]
  3. Daniil Z. D., Gilchrist F. C., Nicholson A. G., Hansell D. M., Harris J., Colby T. V., du Bois R. M. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 1999 Sep;160(3):899–905. doi: 10.1164/ajrccm.160.3.9903021. [DOI] [PubMed] [Google Scholar]
  4. Hubbard R., Lewis S., Richards K., Johnston I., Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet. 1996 Feb 3;347(8997):284–289. doi: 10.1016/s0140-6736(96)90465-1. [DOI] [PubMed] [Google Scholar]
  5. Huopio H., Reimann F., Ashfield R., Komulainen J., Lenko H. L., Rahier J., Vauhkonen I., Kere J., Laakso M., Ashcroft F. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest. 2000 Oct;106(7):897–906. doi: 10.1172/JCI9804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Iwai K., Mori T., Yamada N., Yamaguchi M., Hosoda Y. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med. 1994 Sep;150(3):670–675. doi: 10.1164/ajrccm.150.3.8087336. [DOI] [PubMed] [Google Scholar]
  7. Javaheri S., Lederer D. H., Pella J. A., Mark G. J., Levine B. W. Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition. Chest. 1980 Oct;78(4):591–594. doi: 10.1378/chest.78.4.591. [DOI] [PubMed] [Google Scholar]
  8. Johkoh T., Müller N. L., Cartier Y., Kavanagh P. V., Hartman T. E., Akira M., Ichikado K., Ando M., Nakamura H. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology. 1999 May;211(2):555–560. doi: 10.1148/radiology.211.2.r99ma01555. [DOI] [PubMed] [Google Scholar]
  9. Katzenstein A. L., Myers J. L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1301–1315. doi: 10.1164/ajrccm.157.4.9707039. [DOI] [PubMed] [Google Scholar]
  10. Kolek V. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia. Acta Univ Palacki Olomuc Fac Med. 1994;137:49–50. [PubMed] [Google Scholar]
  11. Marshall R. P., McAnulty R. J., Laurent G. J. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? Int J Biochem Cell Biol. 1997 Jan;29(1):107–120. doi: 10.1016/s1357-2725(96)00141-0. [DOI] [PubMed] [Google Scholar]
  12. Marshall R. P., Puddicombe A., Cookson W. O., Laurent G. J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax. 2000 Feb;55(2):143–146. doi: 10.1136/thorax.55.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. PEABODY J. W., PEABODY J. W., Jr, HAYES E. W., HAYES E. W., Jr Idiopathic pulmonary fibrosis; its occurrence in identical twin sisters. Dis Chest. 1950 Oct;18(4):330–344. doi: 10.1016/s0096-0217(15)34710-5. [DOI] [PubMed] [Google Scholar]
  14. Peltonen L., Jalanko A., Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet. 1999;8(10):1913–1923. doi: 10.1093/hmg/8.10.1913. [DOI] [PubMed] [Google Scholar]
  15. Peltonen L., Palotie A., Lange K. Use of population isolates for mapping complex traits. Nat Rev Genet. 2000 Dec;1(3):182–190. doi: 10.1038/35042049. [DOI] [PubMed] [Google Scholar]
  16. Scott J., Johnston I., Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ. 1990 Nov 3;301(6759):1015–1017. doi: 10.1136/bmj.301.6759.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Vuorio A. F., Turtola H., Piilahti K. M., Repo P., Kanninen T., Kontula K. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3127–3138. doi: 10.1161/01.atv.17.11.3127. [DOI] [PubMed] [Google Scholar]
  18. Whyte M., Hubbard R., Meliconi R., Whidborne M., Eaton V., Bingle C., Timms J., Duff G., Facchini A., Pacilli A. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):755–758. doi: 10.1164/ajrccm.162.2.9909053. [DOI] [PubMed] [Google Scholar]
  19. de la Chapelle A., Wright F. A. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12416–12423. doi: 10.1073/pnas.95.21.12416. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES